Delay in diagnosis of primary osteosarcoma of bone in children: Have we improved in the last 15 years and what is the impact of delay on diagnosis?

Delayed diagnosis Osteosarcoma Pediatric osteosarcoma Prognostic factor Symptom length

Journal

Journal of bone oncology
ISSN: 2212-1366
Titre abrégé: J Bone Oncol
Pays: Netherlands
ID NLM: 101610292

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 20 11 2020
revised: 05 03 2021
accepted: 23 03 2021
entrez: 26 4 2021
pubmed: 27 4 2021
medline: 27 4 2021
Statut: epublish

Résumé

Examine: (1) If length of symptoms (LS) of children with osteosarcoma has improved in the last 15 years (2) Is delay in diagnosis related to the presence of metastases at presentation? (3) The impact of delay in diagnosis on prognosis. 250 consecutive patients with a diagnosis of osteosarcoma of bone treated at a national bone tumor treatment center between 2004 and 2018 were studied retrospectively. Three groups comprising those diagnosed over a five-year period (Group 1: 2004-2008, Group 2: 2009-2013; Group 3: 2014-2018) were studied. There were 126 males and 124 females with a mean age 12.2 years. The median LS for all patients was eight weeks. The median LS for Group 3 was significantly shorter than that for other groups. Development of metastasis during follow-up period was significantly less in Group 3 compared to the other groups. Overall survival gradually improved over the whole study period. There was no difference in the proportion presenting with metastases at diagnosis between the three groups. The survival rates in patients with LS shorter than 4 weeks was better than those with LS longer than 4 weeks, irrespective of the study time period. There has been an improvement in the LS in patients diagnosed with osteosarcoma over the last 15 years. The development of metastasis during follow-up has reduced and the overall survival in the last 15 years has improved. LS longer than 4 weeks is associated with a poorer prognosis.

Identifiants

pubmed: 33898215
doi: 10.1016/j.jbo.2021.100359
pii: S2212-1374(21)00013-0
pmc: PMC8056435
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100359

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Clin Oncol. 2002 Feb 1;20(3):776-90
pubmed: 11821461
Am J Orthop (Belle Mead NJ). 2015 Dec;44(12):547-53
pubmed: 26665241
Acta Radiol Oncol. 1984;23(2-3):159-62
pubmed: 6331085
Hong Kong Med J. 2009 Dec;15(6):434-9
pubmed: 19966347
J Bone Joint Surg Am. 1999 Mar;81(3):317-25
pubmed: 10199269
Pediatr Blood Cancer. 2016 Mar;63(3):479-85
pubmed: 26797893
J Clin Oncol. 2006 Mar 1;24(7):1161-8
pubmed: 16505436
Eur J Cancer. 2004 Oct;40(15):2280-6
pubmed: 15454254
Medicine (Baltimore). 2016 Apr;95(15):e3420
pubmed: 27082623
J Surg Oncol. 2014 Dec;110(8):919-29
pubmed: 25155556
Cancer Treat Res. 2009;152:3-13
pubmed: 20213383
Clinics (Sao Paulo). 2006 Apr;61(2):99-106
pubmed: 16680325
Clin Orthop Relat Res. 2007 Sep;462:181-9
pubmed: 17534186
Bone Joint J. 2018 May 1;100-B(5):652-661
pubmed: 29701086
J Surg Oncol. 2016 Mar;113(4):361-3
pubmed: 26728703
Cancer. 2009 Apr 1;115(7):1531-43
pubmed: 19197972
J Orthop Surg (Hong Kong). 2010 Apr;18(1):55-7
pubmed: 20427835
Tumori. 2000 May-Jun;86(3):204-6
pubmed: 10939599
J Bone Joint Surg Am. 2000 May;82(5):667-74
pubmed: 10819277
Bone Joint J. 2016 Apr;98-B(4):555-63
pubmed: 27037440
Lancet Oncol. 2012 Oct;13(10):e445-59
pubmed: 23026830
Eur J Cancer Care (Engl). 2016 Sep;25(5):849-54
pubmed: 26568464
Clin Orthop Relat Res. 2012 Jul;470(7):2007-13
pubmed: 22354612
J Clin Oncol. 2003 Jan 15;21(2):334-41
pubmed: 12525527
Ann Oncol. 2010 Jun;21(6):1366-1373
pubmed: 19889609
J Pediatr Hematol Oncol. 2002 Jan;24(1):27-30
pubmed: 11902735
J Cancer Res Clin Oncol. 2011 Apr;137(4):597-607
pubmed: 20514491
Orthop Surg. 2016 May;8(2):122-8
pubmed: 27384720

Auteurs

Shinichirou Yoshida (S)

The Royal Orthopaedic Hospital, Bristol Road South, Northfield, Birmingham B31 2AP, Birmingham, UK.
Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.

James Celaire (J)

The Royal Orthopaedic Hospital, Bristol Road South, Northfield, Birmingham B31 2AP, Birmingham, UK.

Chloe Pace (C)

The Royal Orthopaedic Hospital, Bristol Road South, Northfield, Birmingham B31 2AP, Birmingham, UK.

Charles Taylor (C)

The Royal Orthopaedic Hospital, Bristol Road South, Northfield, Birmingham B31 2AP, Birmingham, UK.

Yoichi Kaneuchi (Y)

The Royal Orthopaedic Hospital, Bristol Road South, Northfield, Birmingham B31 2AP, Birmingham, UK.
Department of Orthopaedic Surgery, Fukushima Medical University, Fukushima, Japan 1, Hikarigaoka, Fukushima 960-1295, Japan.

Scott Evans (S)

The Royal Orthopaedic Hospital, Bristol Road South, Northfield, Birmingham B31 2AP, Birmingham, UK.

Adesegun Abudu (A)

The Royal Orthopaedic Hospital, Bristol Road South, Northfield, Birmingham B31 2AP, Birmingham, UK.

Classifications MeSH